Fatal-Plus 390 mg (Pentobarbital Sodium SOLUTION) 390 MG

Fatal-Plus 390 mg is a pentobarbital sodium solution used for veterinary euthanasia. This product is designed for intramuscular administration in animals, providing a humane and rapid solution for pet euthanasia.

Strength

390 MG

Manufacturer / TM Owner

GREY WOLF ANIMAL HEALTH INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Fatal-Plus 390 mg is primarily used for veterinary euthanasia. It is administered to induce a peaceful and painless end for pets when necessary. This solution is formulated to provide a quick and effective method for animal euthanasia, ensuring minimal distress for the animal.

Side Effects

Fatal-Plus 390 mg works by rapidly inducing unconsciousness and respiratory depression. The solution is designed to provide a humane and swift transition, minimizing any discomfort for the animal. It is important to follow proper administration guidelines to ensure the intended effects are achieved.

Precautions & Warnings

Fatal-Plus 390 mg should be handled with care and administered only by trained professionals. It is crucial to follow all safety protocols and guidelines provided by the manufacturer. This solution should be stored securely to prevent accidental access by pets or humans.

Avoid Interactions

Fatal-Plus 390 mg may interact with other medications or substances. It is important to consult with a veterinarian before administering this solution, especially if the animal is currently taking other medications. Always follow the recommended dosage and administration instructions to avoid potential interactions.

Frequently Asked Questions

Fatal-Plus 390 mg is used for veterinary euthanasia, providing a humane and rapid solution for ending the life of a pet when necessary.

Fatal-Plus 390 mg should be administered intramuscularly by a trained professional, following the guidelines provided by the manufacturer.

Fatal-Plus 390 mg induces unconsciousness and respiratory depression, providing a peaceful and painless end for the animal.

Yes, Fatal-Plus 390 mg should be handled with care and administered only by trained professionals. It should be stored securely to prevent accidental access.

Yes, Fatal-Plus 390 mg may interact with other medications. It is important to consult with a veterinarian before administering this solution.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.